EverSource Wealth Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$189K Buy
6,009
+102
+2% +$4.3K 0.01% 1029
2026
Q1
$327K Buy
5,907
+943
+19% +$44.9K 0.01% 805
2025
Q4
$185K Buy
4,964
+731
+17% +$29.7K 0.01% 979
2025
Q3
$171K Buy
4,233
+1,513
+56% +$50K 0.01% 993
2025
Q2
$69.5K Buy
2,720
+2,685
+7,671% +$58.5K ﹤0.01% 1405
2025
Q1
$747 Sell
35
-47
-57% -$1.05K ﹤0.01% 3327
2024
Q4
$1.72K Buy
+82
New +$1.9K ﹤0.01% 2771
2023
Q4
Sell
-66
Closed -$843 2717
2023
Q3
$843 Sell
66
-56
-46% -$794 ﹤0.01% 2288
2023
Q2
$1.67K Buy
+122
New +$1.75K ﹤0.01% 2080
2022
Q3
Sell
-258
Closed -$5K 2087
2022
Q2
$5K Hold
258
﹤0.01% 1279
2022
Q1
$5K Buy
+258
New +$5.21K ﹤0.01% 1273

Other funds holding PAHC

EverSource Wealth Advisors's PAHC Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Phibro Animal Health (PAHC) stake by 1.7% in Q2 2026, buying an estimated $4.3K and bringing the position to 6,009 shares worth $189K. The position accounts for 0.01% of the portfolio, ranked #1029.

EverSource Wealth Advisors first reported a position in PAHC in Q1 2022 and has held it in 11 quarters since. The position peaked at $327K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • EverSource Wealth Advisors held 6,009 shares of Phibro Animal Health worth $189K as of Q2 2026.
  • EverSource Wealth Advisors bought 102 Phibro Animal Health shares in Q2 2026, an estimated $4.3K.
  • Phibro Animal Health made up 0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1029 holding.
  • EverSource Wealth Advisors first reported a position in Phibro Animal Health in Q1 2022 and has held it in 11 quarters since.
  • EverSource Wealth Advisors's Phibro Animal Health position peaked at $327K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.